1st Oct 2013 12:12
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN
Clinigen Group plc
1 October 2013
RESULT OF PLACING
Clinigen Group plc ("Clinigen" or the "Company", AIM: CLIN), announces that it has been notified today that several Directors and employees of Clinigen have today sold a total of 8,723,826 ordinary shares in the Company ("the Placing Shares") on the London Stock Exchange at a price of 410p per share. The Placing Shares represent in aggregate approximately 10.6 per cent of the total issued share capital of Clinigen. The Placing Shares were sold to institutional investors via an accelerated bookbuild placing managed by Numis Securities Limited as bookrunner and joint broker and Peel Hunt LLP as joint broker.
Following this disposal, those Directors of Clinigen who have sold shares in this placing have the following shareholdings in the Company.
Resultant shareholding | |||
Director | Number of Placing Shares sold | Shares | % |
Peter George | 2,832,500 | 6,057,242 | 7.3 |
Robin Sibson | 2,480,516 | 2,480,515 | 3.0 |
Shaun Chilton | 303,800 | 303,800 | 0.4 |
The Directors who have sold shares in this placing have each undertaken (subject to customary exceptions) not to dispose of any further shares in the Company for a period of 180 days from the date of today's placing. The orderly market provisions, which were put in place at the time of the Company's IPO and which apply to all of the Directors and employees who have sold shares in this placing, will continue in force until their scheduled expiry in September 2014.
- Ends -
Enquiries:
Numis Securities Limited | Tel: +44 (0) 20 7260 1000 |
James Black/Tom Ballard/Jamie Loughborough (Corporate Broking) Michael Meade/Freddie Barnfield (Nominated Adviser) | |
Peel Hunt LLP - Joint Broker | Tel: +44 (0) 20 7418 8900 |
Jock Maxwell Macdonald (Corporate Sales & Syndication) James Steel / Dr Vijay Barathan |
Related Shares:
CLIN.L